J2406 HCPCS code: Injection, oritavancin (kimyrsa), 10 mg
J2406 is the HCPCS Level II code for injection, oritavancin (kimyrsa), 10 mg. In 2024 Medicare paid an average of $32.15 per service for J2406 across 152,147 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 120 per day on outpatient hospital claims. Medicare volume rose 43% from 2022 to 2024 (106,306 to 152,147 services). In 2024, about 161 clinicians billed Medicare for J2406 for 807 beneficiaries; Florida, Texas, Georgia accounted for 77% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2021-10-01 |
| Last action effective | 2021-10-01 |
Who bills J2406 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 161 |
| Medicare beneficiaries | 807 |
| States with claims | 9 |
| Share of services in top 3 states (Florida, Texas, Georgia) | 77% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2406, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 106,306 | 568 | $40.82 | $32.54 |
| 2023 | 136,047 | 724 | $40.40 | $32.20 |
| 2024 | 152,147 | 807 | $40.35 | $32.15 |
States with the most J2406 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 62,981 | $32.38 |
| Texas | 27,900 | $31.64 |
| Georgia | 18,760 | $32.34 |
| Michigan | 11,400 | $31.74 |
| Illinois | 6,840 | $32.04 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 120 | Prescribing Information |
| practitioner claims | 120 | Prescribing Information |
What changed for J2406
- 2021-10-01: J2406 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2406?
J2406 is the HCPCS Level II code for injection, oritavancin (kimyrsa), 10 mg. Short descriptor: "Injection, oritavancin 10 mg".
How much does Medicare pay for J2406?
In 2024, the average Medicare payment was $32.15 per service (average allowed $40.35).
Does Medicare cover J2406?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2406 can be billed per day?
120 on outpatient hospital claims; 120 on practitioner claims (NCCI medically unlikely edits).
Related J24 codes
- J2400 — Injection, chloroprocaine hydrochloride, per 30 ml
- J2401 — Injection, chloroprocaine hydrochloride, per 1 mg
- J2402 — Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2403 — Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
- J2404 — Injection, nicardipine, 0.1 mg
- J2405 — Injection, ondansetron hydrochloride, per 1 mg
- J2407 — Injection, oritavancin (orbactiv), 10 mg
- J2410 — Injection, oxymorphone hcl, up to 1 mg
- J2425 — Injection, palifermin, 50 micrograms
- J2426 — Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2427 — Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- J2428 — Injection, paliperidone palmitate extended release (erzofri), 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2406
- Watch J2406 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2406
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.